www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

B7-H3-Directed ADC (Risvutatug rezetecan)

Catalogue number:
BPS-84375-1
Supplier:
Size:
1 mg
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£2393.00 Shipping is calculated in checkout
CAS Number:

3042849-33-9

Purity:

≥98% by SEC-HPLC.

Alternative Names:

CD276, 4Ig-B7-H3, B7 homolog 3 (B7-H3) Costimulatory molecule, B7H3, B7RP-2, HS-20093, GSK5764227

Product Description:

Risvutatug rezetecan, also known as HS-20093 or GSK5764227, is a humanized antibody-drug conjugate (ADC) targeting B7-H3 (CD276). Risvutatug rezetecan binds to B7-H3 on cells and delivers a topoisomerase I inhibitor payload via a tumor microenvironment-responsive cleavable linker.